A who's who of integrity agreements

Share this article:

FDA anger can bring down a corporate integrity agreement on a drug or device maker. Health and Human Services' Office of the Inspector General has a lineup of the pharma companies who are on notice. Of the 20 listed, only one has an end date or has been closed (congratulations, Medtronic).

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.